Skip to content
DraconiticResearch
Search Sources API
197,357 studies31 sourcesUpdated 19 min ago
Peer-reviewedCC BYFrontiers in genetics

Donor-aware multi-cohort single-cell analysis identifies an LXR-linked tubular cholesterol-handling state in membranous nephropathy with a coordinated five-gene lipid-remodeling signature across renal tumors.

4 affiliations
  1. 1Department of Nephrology, Tianshui the Second People's Hospital, Tianshui Cooperation of Chinese and Western Medicine Hospital, Tianshui City, Gansu Province, China.
  2. 2Department of Operating Room, Huai'an Hospital of Huai'an City (Huai'an Clinical Medical College of Jiangsu University), Huai'an City, Jiangsu Province, China.
  3. 3Department of Laboratory, Tianshui the Second People's Hospital, Tianshui Cooperation of Chinese and Western Medicine Hospital, Tianshui City, Gansu Province, China.
  4. 4Department of Hemodialysis Center, Huzhou Wuxing Hospital of Traditional Chinese and Western Medicine, Huzhou City, Zhejiang Province, China.

Abstract

Background

Membranous nephropathy (MN) is an immune-mediated glomerular disease in which sustained proteinuria exposes renal tubular epithelial cells to an abnormal filtered-protein load. The tubular metabolic response to this exposure remains incompletely characterized. We investigated whether MN is associated with a reproducible tubular cholesterol-handling transcriptional state and assessed its relationship to protein overload in vitro. We further evaluated whether an experimentally anchored five-gene subset showed a coordinated tumor-associated transcriptional shift across major renal cancer histologies.Methods

Three kidney single-cell RNA-sequencing datasets and one glomerular bulk-transcriptomic cohort were analyzed using the donor as the biological replicate. GSE241302 was used for complete-case exploratory discovery, OEP004186 for formal donor-aware support, GSE171458 for directional support, and GSE200828 for tissue-level disease context. A frozen 47-gene LXR-linked cholesterol-handling program and its nested 37-gene cholesterol transport/efflux component were evaluated by donor-level pseudobulk analysis, leave-one-donor-out and leave-one-gene-out sensitivity analyses. HK-2 cells were exposed to protein overload, followed by quantitative reverse-transcription PCR for representative transport and lipid-remodeling genes. The same experimentally anchored five-gene panel was then evaluated in 129 paired tumor-adjacent-normal samples across TCGA-KIRC, TCGA-KIRP, and TCGA-KICH to define a renal tumor-associated lipid-remodeling context.Results

Across all 3 MN donors in GSE241302, program scores were higher than the internal reference in proximal tubule (PT) and loop-of-Henle/thick ascending limb (loop/TAL) compartments. In OEP004186, the program was increased in PT (effect +0.480, false-discovery rate [FDR] 0.0128), PT-VCAM1 (+0.348, FDR 0.0165), and loop/distal epithelial cells (+0.310, FDR 0.0242), with positive effects in every leave-one-MN-donor-out analysis. GSE171458 provided concordant directional support in PT and loop/TAL. The PT-VCAM1 fraction was not increased in MN, whereas the program remained higher within both PT and PT-VCAM1, favoring a within-state transcriptional change. Sixteen program genes showed positive average effects across the three single-cell resources. In GSE200828, the overall program was higher in MN than in living donors (+0.226, FDR 0.0349) but not higher than in other glomerular diseases. Protein overload increased ABCA1, ABCG1, SREBF1, FASN, and SCD expression in HK-2 cells. Across the three renal cancer histologies, the five-gene panel showed a concordant paired increase (REML-pooled effect +0.967, 95% CI 0.843-1.092), and 85.3% of patients exhibited simultaneous increases in the cholesterol-efflux and lipid-synthesis/remodeling arms.Conclusion

MN is associated with a donor-supported LXR-linked cholesterol-handling transcriptional state concentrated in PT and loop/TAL-related epithelial compartments. The state is responsive to protein overload in HK-2 cells and may reflect a broader tubular lipid-homeostasis response to proteinuric kidney injury. The data do not establish direct LXR activation, increased cholesterol-efflux flux, or MN specificity. The paired renal cancer analysis further identifies a coordinated tumor-associated five-gene lipid-remodeling signature across KIRC, KIRP, and KICH, while not establishing tumor-cell-intrinsic LXR activation, immune effects, or a causal tumor mechanism.

Related

  1. Influence of Occupational Exposures on Cytokine Profiles in Patients with Membranous Nephropathy
    Maxime Teisseyre, Mounir El Mai, Marion Cremoni +1
    Kidney international reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMCEurope PMCPMC
  2. A case of recurrent membranous nephropathy with multiple necrotizing pulmonary nodules
    Zeng Wei-ling, Zhou Xian-ke, Du Dan-dan +5
    Linchuang shenzangbing zazhiPeer-reviewedCC BY-NC-NDFull textGeneral medicineDOAJ
  3. Sustained remission of NELL-1-positive membranous nephropathy after lung adenocarcinoma resection and during subsequent atezolizumab therapy in a 68-year-old man: a case report
    Masafumi Ikezawa, Yasuyuki Ikezawa, Mina Eguchi +8
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  4. Cronkhite-Canada Syndrome Associated with Primary Cutaneous Peripheral T-cell Lymphoma and Membranous Nephropathy: A Case Report
    Kohei Kiso, Yusuke Shimoyama, Saki Okuda-Hiwatashi +11
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE
  5. Rapidly progressive glomerulonephritis revealing the coexistence of diabetic nephropathy, membranous nephropathy, and MPO-ANCA-associated crescentic glomerulonephritis.
    Sarra Hadded, Rania Kandil, Hanene Gaied +5
    Clinical nephrology. Case studiesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{mao2026donoraware,
  title = {{Donor-aware multi-cohort single-cell analysis identifies an LXR-linked tubular cholesterol-handling state in membranous nephropathy with a coordinated five-gene lipid-remodeling signature across renal tumors.}},
  author = {Yalan Mao and Ran Li and Bin Li and Hongfen Pan},
  journal = {Frontiers in genetics},
  year = {2026},
  month = oct,
  doi = {10.3389/fgene.2026.1916595},
  url = {https://europepmc.org/article/MED/42948845},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Donor-aware multi-cohort single-cell analysis identifies an LXR-linked tubular cholesterol-handling state in membranous nephropathy with a coordinated five-gene lipid-remodeling signature across renal tumors.
AU  - Yalan Mao
AU  - Ran Li
AU  - Bin Li
AU  - Hongfen Pan
PY  - 2026
DA  - 2026/10/14
JO  - Frontiers in genetics
DO  - 10.3389/fgene.2026.1916595
UR  - https://europepmc.org/article/MED/42948845
AB  - Background  Membranous nephropathy (MN) is an immune-mediated glomerular disease in which sustained proteinuria exposes renal tubular epithelial cells to an abnormal filtered-protein load. The tubular metabolic response to this exposure remains incompletely characterized. We investigated whether MN is associated with a reproducible tubular cholesterol-handling transcriptional state and assessed its relationship to protein overload in vitro. We further evaluated whether an experimentally anchored five-gene subset showed a coordinated tumor-associated transcriptional shift across major renal cancer histologies.Methods  Three kidney single-cell RNA-sequencing datasets and one glomerular bulk-transcriptomic cohort were analyzed using the donor as the biological replicate. GSE241302 was used for complete-case exploratory discovery, OEP004186 for formal donor-aware support, GSE171458 for directional support, and GSE200828 for tissue-level disease context. A frozen 47-gene LXR-linked cholesterol-handling program and its nested 37-gene cholesterol transport/efflux component were evaluated by donor-level pseudobulk analysis, leave-one-donor-out and leave-one-gene-out sensitivity analyses. HK-2 cells were exposed to protein overload, followed by quantitative reverse-transcription PCR for representative transport and lipid-remodeling genes. The same experimentally anchored five-gene panel was then evaluated in 129 paired tumor-adjacent-normal samples across TCGA-KIRC, TCGA-KIRP, and TCGA-KICH to define a renal tumor-associated lipid-remodeling context.Results  Across all 3 MN donors in GSE241302, program scores were higher than the internal reference in proximal tubule (PT) and loop-of-Henle/thick ascending limb (loop/TAL) compartments. In OEP004186, the program was increased in PT (effect +0.480, false-discovery rate [FDR] 0.0128), PT-VCAM1 (+0.348, FDR 0.0165), and loop/distal epithelial cells (+0.310, FDR 0.0242), with positive effects in every leave-one-MN-donor-out analysis. GSE171458 provided concordant directional support in PT and loop/TAL. The PT-VCAM1 fraction was not increased in MN, whereas the program remained higher within both PT and PT-VCAM1, favoring a within-state transcriptional change. Sixteen program genes showed positive average effects across the three single-cell resources. In GSE200828, the overall program was higher in MN than in living donors (+0.226, FDR 0.0349) but not higher than in other glomerular diseases. Protein overload increased ABCA1, ABCG1, SREBF1, FASN, and SCD expression in HK-2 cells. Across the three renal cancer histologies, the five-gene panel showed a concordant paired increase (REML-pooled effect +0.967, 95% CI 0.843-1.092), and 85.3% of patients exhibited simultaneous increases in the cholesterol-efflux and lipid-synthesis/remodeling arms.Conclusion  MN is associated with a donor-supported LXR-linked cholesterol-handling transcriptional state concentrated in PT and loop/TAL-related epithelial compartments. The state is responsive to protein overload in HK-2 cells and may reflect a broader tubular lipid-homeostasis response to proteinuric kidney injury. The data do not establish direct LXR activation, increased cholesterol-efflux flux, or MN specificity. The paired renal cancer analysis further identifies a coordinated tumor-associated five-gene lipid-remodeling signature across KIRC, KIRP, and KICH, while not establishing tumor-cell-intrinsic LXR activation, immune effects, or a causal tumor mechanism.
SN  - 1664-8021
ER  -